tagraxofusp

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

tagraxofusp

Jun 7, 2024, 00:51 | Blog

BPDCN treatment and management CD123-targeting agents the Video Journal of Hematology and Hematological Oncology podcast covers

Video Journal of Hematology and Hematological Oncology shared on their LinkedIn: ''NEW podcast episode: BPDCN…

Apr 21, 2024, 21:27 | Drugs

Hagop Kantarjian: We review the evidence leading to Tagraxofusp approval as first in class CD123-directed drug which has changed the field of BPDCN

Hagop Kantarjian, Leukaemia professor and Chair at MD Anderson Cancer Center, shared on X: “Tazgraxofusp is…

Apr 19, 2024, 20:20 | Drugs

This new review article is all about Tagraxofusp for BPDCN - ACS Journal Cancer

ACS Journal Cancer recently shared on X: "This new review article from Wei Ying Jen,…

Feb 26, 2024, 19:07 | Blog

Naveen Pemmaraju: Our brand new paper just out in L and L

Naveen Pemmaraju posted on X/Twitter: “Delighted to share our brand new paper just out in…

All: 4 Posts: 1 - 100